Ingevity NGVT Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $258M+1.1% | $255.1M-23.4% | $333.1M-8.8% | $365.1M+47.3% | $247.9M-5.8% | ||
| $141.6M-15.4% | $167.3M-16.0% | $199.2M-12.3% | $227.2M+67.1% | $136M-16.8% | ||
| $116.4M+32.6% | $87.8M-34.4% | $133.9M-2.9% | $137.9M+23.2% | $111.9M+12.0% | ||
| 45.1%+10.7pp | 34.4%-5.8pp | 40.2%+2.4pp | 37.8%-7.4pp | 45.1%+7.2pp | ||
| $6.7M-9.5% | $7.4M+5.7% | $7M-10.3% | $7.8M+11.4% | $7M+7.7% | ||
| $40.7M-2.2% | $41.6M-5.7% | $44.1M-0.2% | $44.2M+5.5% | $41.9M+9.4% | ||
| -$15.9M-112% | $134.7M+832% | -$18.4M+1.1% | -$18.6M+4.1% | -$19.4M-112% | ||
| $30.2M+129% | -$105.4M-269% | $62.2M+144% | -$142.7M-480% | $37.6M— | ||
| $6.8M— | —— | $21.4M+463% | $3.8M-55.3% | $8.5M— | ||
| $59.8M+171% | -$84.6M-294% | $43.5M+130% | -$146.5M-815% | $20.5M— | ||
| 23.2%+56.3pp | -33.2%-46.2pp | 13.1%+53.2pp | -40.1%-48.4pp | 8.3%+8.3pp | ||
| $1.66+171% | -$2.34-298% | $1.18+129% | -$4.02-818% | $0.56— | ||
| $37M-35.3% | $57.2M-20.3% | $71.8M+153% | -$135.7M-415% | $43.1M— | ||
| 14.3%-8.1pp | 22.4%+0.9pp | 21.6%+58.7pp | -37.2%-54.6pp | 17.4%— | ||
| $14.3M-51.2% | $29.3M-33.1% | $43.8M+127% | -$161.3M-986% | $18.2M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Ingevity's revenue?
- Ingevity (NGVT) generated $1.2B in revenue over the trailing twelve months, down 2.0% year over year.
- Is Ingevity profitable?
- Ingevity is not currently profitable: it reported a net loss of $127.8M over the trailing twelve months, a -10.6% net margin.
- What is Ingevity's earnings per share?
- Ingevity's diluted EPS over the trailing twelve months is $-3.52.
- Where does Ingevity's income statement data come from?
- Every line is extracted from Ingevity's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
